Kevin Jang; Michael Back · 2025 · Brain Sciences
Paper
Glioblastoma (GBM) often exhibits distinct anatomical patterns of relapse after radiotherapy. Tumour cell migration along myelinated white matter tracts is a key driver of disease progression. The failure of conventional imaging to capture subclinical infiltration has driven interest in advanced imaging biomarkers capable of quantifying tumour–brain interactions. Diffusion tensor imaging (DTI), radiomics, and connectomics represent a triad of innovative, non-invasive approaches that map white matter architecture, predict recurrence risk, and inform biologically guided treatment strategies. This review examines the biological rationale and clinical applications of DTI-based metrics, radiomic signatures, and tractography-informed connectomics in GBM. We discuss the integration of these modalities into machine learning frameworks and radiotherapy/surgical planning, supported by landmark studies and multi-institutional data. The implications for personalised neuro-oncology are profound, marking a shift towards risk-adaptive, tract-aware treatment strategies that may improve local control and preserve neurocognitive function.
Analysis
This review explores the integration of Diffusion Tensor Imaging (DTI), radiomics, and connectomics to predict glioblastoma (GBM) recurrence by mapping tumour infiltration along white matter tracts.
Discovery
Zhong M; Zhang M; Wang F; Wang Y; Chen Z; Liu Z; Yang J
Li Y; Wang D; Zhou R; Yan S; Wang D; Wei Y; Yao H; Zhou B; Lu J; Wang P; Liao Z; Han Y; Zhang X; Zhang Y; Liu Y; Zhao K; Alzheimer's Disease Neuroimaging Initiative
Hirsch F; Frontzkowski L; Steward A; Roemer-Cassiano SN; Biel D; Zhu Z; Palleis C; Gnörich J; Klonowski M; Höglinger G; Brendel M; Franzmeier N
Guo XY; Zheng Y; Zhao LQ; Shang H; Yang W
Harasymiw L; Kuang A; Xu D; Scheffler A; George E; Peyvandi S; McQuillen P
Hu AM; Ma YL; Li YX; Shi QL; Zhang YM
Source record